In a recent phase 1/2 clinical trial, AIM ImmunoTech has announced encouraging results from its study involving ovarian cancer patients.…
In a recent phase 1/2 clinical trial, AIM ImmunoTech has announced encouraging results from its study involving ovarian cancer patients.…
AIM ImmunoTech Inc. (AIM) has achieved a significant breakthrough in ovarian cancer treatment. As evidenced by the positive data from…
Login below or Register Now.
Already registered? Login.